Bausch Health Companies Inc BHC-CA:Toronto Stock Exchange

*Data is delayed | Exchange | CAD

Last | 12/07/22 EST

9.82UNCH (UNCH)

52 week range

5.10 - 36.26

Open0.00
Day High0.00
Day Low0.00
Prev Close9.82
52 Week High36.26
52 Week High Date12/29/21
52 Week Low5.10
52 Week Low Date07/28/22

Key Stats

Market Cap2,870.59M
Shares Out361.78M
10 Day Average Volume2.65M
Dividend-
Dividend Yield-
Beta0.87
YTD % Change-71.89

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close9.82
52 Week High36.26
52 Week High Date12/29/21
52 Week Low5.10
52 Week Low Date07/28/22
Market Cap2,870.59M
Shares Out361.78M
10 Day Average Volume2.65M
Dividend-
Dividend Yield-
Beta0.87
YTD % Change-71.89

RATIOS/PROFITABILITY

EPS (TTM)0.97
P/E (TTM)10.18
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date05/17/2007
Div Amount0.375
Split Date-
Split Factor-

Latest On Bausch Health Companies Inc

November Monthly Meeting: Cramer reveals 10 core holdings for this marketNovember 17, 2022CNBC.com
Hedge funds were busy trading Club holdings last quarterNovember 15, 2022CNBC.com
One of our best-performing stocks lately reports earnings this week. What to expectNovember 14, 2022CNBC.com
After this week's big market rally, here's a rapid-fire update on all 32 Club stocksNovember 11, 2022CNBC.com
These Club stocks have been big winners in prior post-midterm market advancesNovember 8, 2022CNBC.com

Content From Our Affiliates

There is no recent news for this security.

Profile

Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in...

John Paulson

Independent Chairman of the Board

Joseph Papa

Chief Executive Officer

Sam Eldessouky

Chief Financial Officer, Executive Vice President

Christina Ackermann

Executive Vice President, General Counsel and Head of Commercial Operations

Address

2150 Saint-Elzear Blvd W

Laval, QC

H7L 4A8

Canada

https://www.bauschhealth.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
GUD
HLS
CWEB Direxion Daily CSI China Internet Bull 2X Shares	50.04	UNCH	UNCH
OPNT Opiant Pharmaceuticals Inc	20.20	UNCH	UNCH
CPH